Ekaterina Balaian

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss.

Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss.

Journal: HemaSphere

Published: September 01, 2025

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series.

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series.

Journal: British journal of haematology

Published: July 05, 2025

Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.

Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.

Journal: American journal of hematology

Published: June 25, 2025

Challenging Situations in the Treatment of Cancer-Associated Thrombosis.

Challenging Situations in the Treatment of Cancer-Associated Thrombosis.

Journal: Hamostaseologie

Published: December 04, 2024

Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS.

Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS.

Journal: HemaSphere

Published: February 28, 2024

VEXAS syndrome: complete molecular remission after hypomethylating therapy.

VEXAS syndrome: complete molecular remission after hypomethylating therapy.

Journal: Annals of hematology

Published: December 10, 2023

Myelodysplastic Syndromes and Metabolism.

Myelodysplastic Syndromes and Metabolism.

Journal: International journal of molecular sciences

Published: September 10, 2021

Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes.

Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes.

Journal: Scientific reports

Published: September 08, 2021

Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.

Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.

Journal: Cancer chemotherapy and pharmacology

Published: July 21, 2021

Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.

Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.

Journal: JCI insight

Published: February 11, 2020

Treatment of Pegylated Asparaginase-Induced Hypertriglyceridemia with Continuous Intravenous Infusion of Insulin and Heparin: A Case Report.

Treatment of Pegylated Asparaginase-Induced Hypertriglyceridemia with Continuous Intravenous Infusion of Insulin and Heparin: A Case Report.

Journal: Chemotherapy

Published: October 24, 2019

Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes.

Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes.

Journal: Annals of hematology

Published: February 12, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026